Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bali Pulendran

Showing results (181-190 of 262) with videos related to

Pageof 27
Sort By:
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Research Square|February 8, 2022
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Med (New York, N.Y.)|May 19, 2022
Durability of immune responses to the BNT162b2 mRNA vaccineMehul S Suthar, Prabhu S Arunachalam, Mengyun Hu, et al.
Cell Host & Microbe|October 23, 2012
A Blueprint for HIV Vaccine DiscoveryDennis R Burton, Rafi Ahmed, Dan H Barouch, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|April 17, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Nature Communications|October 5, 2023
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
The Journal of Infectious Diseases|July 5, 2008
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genesBali Pulendran, Joseph Miller, Troy D Querec, et al.
Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Pageof 27

Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Research Square|February 8, 2022
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Med (New York, N.Y.)|May 19, 2022
Durability of immune responses to the BNT162b2 mRNA vaccineMehul S Suthar, Prabhu S Arunachalam, Mengyun Hu, et al.
Cell Host & Microbe|October 23, 2012
A Blueprint for HIV Vaccine DiscoveryDennis R Burton, Rafi Ahmed, Dan H Barouch, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|April 17, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Nature Communications|October 5, 2023
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
The Journal of Infectious Diseases|July 5, 2008
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genesBali Pulendran, Joseph Miller, Troy D Querec, et al.
Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Pageof 27